Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
New Horizons (Baltimore, Md.)
|
November 1, 1993
Neutrophils and neutrophil-endothelial cell adhesion in adult respiratory distress syndrome
C H Wortel, C M Doerschuk
International Journal of Psychiatry in Medicine
|
January 1, 1991
Psychogenic "HIV infection"
H N Sno, J G Storosum, C H Wortel
Neurosurgery
|
February 5, 1999
Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas
T F Cloughesy, K L Black, Y P Gobin, et al.
Zeitschrift Fur Medizinische Laboratoriumsdiagnostik
|
January 1, 1990
Detection and clinical relevance of human endotoxemia
A Sturk, S J van Deventer, C H Wortel, et al.
Alimentary Pharmacology & Therapeutics
|
July 14, 2005
Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease
A Kasran, L Boon, C H Wortel, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 13, 1993
[Immunotherapy using the anti-endotoxin antibody HA-1A in patients with sepsis syndrome; good results in relation to treatment with placebo]
C H Wortel, M A von der Möhlen, S J van Deventer, et al.
Surgery
|
September 1, 1993
Interleukin-6 mediates host defense responses induced by abdominal surgery
C H Wortel, S J van Deventer, L A Aarden, et al.
The Journal of Infectious Diseases
|
December 1, 1992
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels
C H Wortel, M A von der Möhlen, S J van Deventer, et al.
The New England Journal of Medicine
|
February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group
E J Ziegler, C J Fisher, C L Sprung, et al.
The New England Journal of Medicine
|
June 7, 1990
Activation of coagulation after administration of tumor necrosis factor to normal subjects
T van der Poll, H R Büller, H ten Cate, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
New Horizons (Baltimore, Md.)
|
November 1, 1993
Neutrophils and neutrophil-endothelial cell adhesion in adult respiratory distress syndrome
C H Wortel, C M Doerschuk
International Journal of Psychiatry in Medicine
|
January 1, 1991
Psychogenic "HIV infection"
H N Sno, J G Storosum, C H Wortel
Neurosurgery
|
February 5, 1999
Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas
T F Cloughesy, K L Black, Y P Gobin, et al.
Zeitschrift Fur Medizinische Laboratoriumsdiagnostik
|
January 1, 1990
Detection and clinical relevance of human endotoxemia
A Sturk, S J van Deventer, C H Wortel, et al.
Alimentary Pharmacology & Therapeutics
|
July 14, 2005
Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease
A Kasran, L Boon, C H Wortel, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 13, 1993
[Immunotherapy using the anti-endotoxin antibody HA-1A in patients with sepsis syndrome; good results in relation to treatment with placebo]
C H Wortel, M A von der Möhlen, S J van Deventer, et al.
Surgery
|
September 1, 1993
Interleukin-6 mediates host defense responses induced by abdominal surgery
C H Wortel, S J van Deventer, L A Aarden, et al.
The Journal of Infectious Diseases
|
December 1, 1992
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels
C H Wortel, M A von der Möhlen, S J van Deventer, et al.
The New England Journal of Medicine
|
February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group
E J Ziegler, C J Fisher, C L Sprung, et al.
The New England Journal of Medicine
|
June 7, 1990
Activation of coagulation after administration of tumor necrosis factor to normal subjects
T van der Poll, H R Büller, H ten Cate, et al.
Page
of 1